Cargando…

FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is the most common soft tissue cancer in children. Treatment outcomes, particularly for relapsed/refractory or metastatic disease, have not improved in decades. The current lack of novel therapies and low tumor mutational burden suggest that chimeric antigen receptor (CAR) T-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sullivan, Peter M., Kumar, Rajesh, Li, Wei, Hoglund, Virginia, Wang, Lingyan, Zhang, Yue, Shi, Megan, Beak, Dusan, Cheuk, Adam, Jensen, Michael C., Khan, Javed, Dimitrov, Dimiter S., Orentas, Rimas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Models and Technologies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538595/ https://www.ncbi.nlm.nih.gov/pubmed/35877472 http://dx.doi.org/10.1158/1535-7163.MCT-22-0059

Ejemplares similares

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
por: Tian, Meijie, et al.
Publicado: (2023)

Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory
por: Martinez-Velez, Naiara, et al.
Publicado: (2022)

Chimeric engulfment receptors: A new cell therapy approach for SIV and HIV infection
por: Orentas, Rimas J.
Publicado: (2023)

Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction
por: Durrant, David E., et al.
Publicado: (2021)

Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing
por: Inoue, Tomoyoshi, et al.
Publicado: (2021)

Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling
por: Surman, Deborah R., et al.
Publicado: (2021)

Anti-CD19 CAR T Cells That Secrete a Biparatopic Anti-CLEC12A Bridging Protein Have Potent Activity Against Highly Aggressive Acute Myeloid Leukemia In Vitro and In Vivo
por: Rennert, Paul D., et al.
Publicado: (2021)

Novel Group C Oncolytic Adenoviruses Carrying a miRNA Inhibitor Demonstrate Enhanced Oncolytic Activity In Vitro and In Vivo
por: Doerner, Johannes, et al.
Publicado: (2022)

CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization
por: Werr, Lisa, et al.
Publicado: (2022)

B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
por: Zhang, Shihong, et al.
Publicado: (2022)

Transcription Factor–Forced Astrocytic Differentiation Impairs Human Glioblastoma Growth In Vitro and In Vivo
por: Trovato, Francesco, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation–Positive, MET-Amplified Non–Small Cell Lung Cancer Model
por: Jones, Rhys D.O., et al.
Publicado: (2023)

An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2023)

Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer
por: Lee, Catherine, et al.
Publicado: (2023)

Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22
por: Sun, Zehua, et al.
Publicado: (2022)

Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
por: Tschernia, Nicholas, et al.
Publicado: (2014)

Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)
por: Li, Samuel Q., et al.
Publicado: (2013)

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
por: Wu, Jerry T., et al.
Publicado: (2023)

Lessons learned from a highly-active CD22-specific chimeric antigen receptor
por: Long, Adrienne H., et al.
Publicado: (2013)

Enhanced glycolytic metabolism is associated with exhaustion and poor antitumor efficacy in a xenograft model of chimeric antigen receptor T cell therapy for sarcoma
por: Long, Adrienne H, et al.
Publicado: (2013)

CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
por: Timpanaro, Andrea, et al.
Publicado: (2023)

Neutralization of murine myeloid-derived suppressor cells enhances the efficacy of a chimeric antigen receptor T-cells directed against pediatric solid tumors
por: Highfill, Steven L, et al.
Publicado: (2013)

Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)
por: Schneider, Dina, et al.
Publicado: (2015)

Bryostatin Activates CAR T-Cell Antigen-Non-Specific Killing (CTAK), and CAR-T NK-Like Killing for Pre-B ALL, While Blocking Cytolysis of a Burkitt Lymphoma Cell Line
por: Wang, Lingyan, et al.
Publicado: (2022)

A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid Leukemia
por: Schneider, Dina, et al.
Publicado: (2018)

Integrating spatially explicit indices of abundance and habitat quality: an applied example for greater sage‐grouse management
por: Coates, Peter S., et al.
Publicado: (2015)

TMOD-05. GENOME-WIDE DNA METHYLATION PROFILE: A POWERFUL STRATEGY TO RECAPITULATE HETEROGENEITY OF PEDIATRIC BRAIN TUMORS IN PRIMARY CELL LINES
por: Pedace, Lucia, et al.
Publicado: (2021)

TMOD-06. LOSS OF DICER COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE METASTATIC MEDULLOBLASTOMA
por: Alcantara Llaguno, Sheila, et al.
Publicado: (2021)

Genetic mouse models of autism spectrum disorder present subtle heterogenous cardiac abnormalities
por: Assimopoulos, Stephania, et al.
Publicado: (2022)

Altered medial prefrontal cortex and dorsal raphé activity predict genotype and correlate with abnormal learning behavior in a mouse model of autism‐associated 2p16.3 deletion
por: Hughes, Rebecca B., et al.
Publicado: (2022)

Reduced brain volume and white matter alterations in Shank3‐deficient rats
por: Golden, Carla E. M., et al.
Publicado: (2021)

Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma
por: Fiorito, Elisa, et al.
Publicado: (2022)

Atomic nuclei: basic building blocks of matter / Атомни ядра: oсновни градивни клетки на материята
por: Balabanski, Dimiter
Publicado: (2012)

Atomic nuclei: basic building blocks of matter / Атомни ядра: oсновни градивни клетки на материята
por: Balabanski, Dimiter
Publicado: (2013)

Atomic nuclei:basic building blocks of matter and fuel of the stars/ Атомните ядра: основни градивни клетки на материята и гориво на звездите
por: Dimiter Balabanski
Publicado: (2008)

Dynamic Processes in Soap Films
por: Mysels, Karol J.
Publicado: (1968)

Permeability and Electrical Properties of Thin Lipid Membranes
por: Finkelstein, Alan, et al.
Publicado: (1968)

The Structure of a Model Membrane in Relation to the Viscoelastic Properties of the Red Cell Membrane
por: Rand, R. P.
Publicado: (1968)

Black Lipid Membranes at Bifaces : Formation characteristics, optical and some thermodynamic properties
por: Ti Tien, H.
Publicado: (1968)

Extension of Nakagawa & Schielzeth's R(2)(GLMM) to random slopes models
por: Johnson, Paul CD
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3dnkmdj438cq5c1mhjon89e15e